Drug Type Monoclonal antibody |
Synonyms Rheumatoid Arthritis (Albatroz Therapeutics) |
Target |
Mechanism CANX inhibitors(calnexin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Discovery | SG | 17 Aug 2024 |